These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15236763)

  • 1. Age-dependent differences in the efficacy of cancer immunotherapy in C57BL and AKR mouse strains.
    Kaptzan T; Skutelsky E; Itzhaki O; Sinai J; Michowitz M; Yossipov Y; Schiby G; Leibovici J
    Exp Gerontol; 2004 Jul; 39(7):1035-48. PubMed ID: 15236763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of anti-angiogenic treatment of tumors in old versus young mice.
    Kaptzan T; Skutelsky E; Itzhaki O; Sinai J; Huszar M; Siegal A; Ben-Zvi R; Jossiphov J; Michowitz M; Schiby G; Leibovici J
    Mech Ageing Dev; 2006 Apr; 127(4):398-409. PubMed ID: 16476469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing ageing conditions in tumour microenvironment-a new possible modality for cancer treatment.
    Leibovici J; Itzhaki O; Kaptzan T; Skutelsky E; Sinai J; Michowitz M; Asfur R; Siegal A; Huszar M; Schiby G
    Mech Ageing Dev; 2009; 130(1-2):76-85. PubMed ID: 18455752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunobiology of aging and cancer.
    Weksler ME; Tsuda T; Kim YT; Siskind GW
    Cancer Detect Prev; 1990; 14(6):609-11. PubMed ID: 2257557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New strategy of cancer immunotherapy: irradiation or chemotherapeutics-induced lymphopenia combined with immune reconstitution and tumor vaccine].
    Ma J; Wang YL; Hu HM; Fox BA; Si LS
    Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):452-6. PubMed ID: 16188138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
    Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
    Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor--secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors.
    Li B; VanRoey M; Wang C; Chen TH; Korman A; Jooss K
    Clin Cancer Res; 2009 Mar; 15(5):1623-34. PubMed ID: 19208793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased DNA ploidy may constitute a mechanism of the reduced malignant behavior of B16 melanoma in aged mice.
    Itzhaki O; Skutelsky E; Kaptzan T; Siegal A; Sinai J; Schiby G; Michowitz M; Huszar M; Leibovici J
    Exp Gerontol; 2008 Mar; 43(3):164-75. PubMed ID: 18261868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD4+ T-cell immunity.
    Mangsbo SM; Ninalga C; Essand M; Loskog A; Tötterman TH
    J Immunother; 2008 Jan; 31(1):34-42. PubMed ID: 18157010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
    Stagg J; Wu JH; Bouganim N; Galipeau J
    Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Bacillus Calmette-Guérin and levamisole on immune responses in young adult and age-immunodepressed mice.
    Bruley-Rosset M; Florentin I; Kiger N; Davigny M; Mathé G
    Cancer Treat Rep; 1978 Nov; 62(11):1641-50. PubMed ID: 728893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of cytokines to enhance vaccine effects of heat shock protein 70-rich tumor cell lysate.
    Ito A; Fujioka M; Tanaka K; Kobayashi T; Honda H
    J Biosci Bioeng; 2005 Jul; 100(1):36-42. PubMed ID: 16233848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced tumorigenicity of B16-F10 mouse melanoma cells transfected with mycobacterial antigen 85A.
    Tarrant JP; Walsh MJ; Blanchard MC; Lee TD; Hoskin DW; Giacomantonio CA
    Int J Oncol; 2004 Dec; 25(6):1693-9. PubMed ID: 15547707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Established B16 tumors are rejected following treatment with GM-CSF-secreting tumor cell immunotherapy in combination with anti-4-1BB mAb.
    Li B; Lin J; Vanroey M; Jure-Kunkel M; Jooss K
    Clin Immunol; 2007 Oct; 125(1):76-87. PubMed ID: 17706463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer immunotherapy based on killing of Salmonella-infected tumor cells.
    Avogadri F; Martinoli C; Petrovska L; Chiodoni C; Transidico P; Bronte V; Longhi R; Colombo MP; Dougan G; Rescigno M
    Cancer Res; 2005 May; 65(9):3920-7. PubMed ID: 15867392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of BCG-activated macrophages on the B-16 melanoma.
    Papilian-Todoruţiu C; Rişcă R; Mulea R; Daicoviciu D
    Rom J Morphol Embryol; 1990; 36(2):129-34. PubMed ID: 2149421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age dependence of motor activity and sensitivity to dopamine receptor 1 agonist, SKF82958, of inbred AKR/J, BALB/c, C57BL/6J, SAMR1, and SAMP6 strains.
    Niimi K; Takahashi E; Itakura C
    Brain Res; 2009 Jan; 1250():175-82. PubMed ID: 19007759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity.
    Machlenkin A; Goldberger O; Tirosh B; Paz A; Volovitz I; Bar-Haim E; Lee SH; Vadai E; Tzehoval E; Eisenbach L
    Clin Cancer Res; 2005 Jul; 11(13):4955-61. PubMed ID: 16000595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The mechanism of anti-tumor immune response against mouse melanoma to xenogeneic vaccination].
    Luo F; Mao YQ; Kan B; He QM; Jiang Y; Peng F; Yang L; Tian L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):757-60. PubMed ID: 15573746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.